Text: The analysis also discusses the regulatory alternatives FDA considered in drafting the proposed rule.
Entailment: The regulatory alternatives FDA considered in drafting the proposed rule are also discussed in the analysis.
Contradiction: The analysis does not discuss the regulatory alternatives FDA considered in drafting the proposed rule.